These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 17366784

  • 1. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
    Tong XD, Liu HX, Zhao HR, Xu SG, Li Y, Han LB, Zhang L.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
    [Abstract] [Full Text] [Related]

  • 2. [Expression and clinical significance of MAPK in non-small cell lung cancer].
    Zhang ZF, Ma JQ, Zhang L.
    Zhonghua Yi Xue Za Zhi; 2005 Feb 02; 85(5):339-42. PubMed ID: 15854513
    [Abstract] [Full Text] [Related]

  • 3. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S, Garayoa M, López-Picazo JM, Lozano MD, Toledo G, Thunnissen FB, Manzano RG, Montuenga LM.
    Clin Cancer Res; 2004 Jun 01; 10(11):3639-49. PubMed ID: 15173070
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 01; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 5. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q, Zhu RQ, Fang Z, Xia D, Diao LM, Liu MQ.
    Ai Zheng; 2005 Mar 01; 24(3):321-6. PubMed ID: 15757534
    [Abstract] [Full Text] [Related]

  • 6. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L, Calcinai A, Samaritani E, Pistolesi F, Mussi A, Lucchi M, Angeletti CA, Basolo F, Fontanini G.
    Br J Cancer; 2000 Aug 01; 83(4):480-6. PubMed ID: 10945495
    [Abstract] [Full Text] [Related]

  • 7. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.
    Cancer; 2007 Jul 01; 110(1):215-23. PubMed ID: 17508409
    [Abstract] [Full Text] [Related]

  • 8. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J, Xu YJ, Zhang ZX, DU CL, Qiao LF, Ni W, Chen SX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct 01; 30(10):771-5. PubMed ID: 18218209
    [Abstract] [Full Text] [Related]

  • 9. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L, Chen J, Ke Y, Mansel RE, Jiang WG.
    Int J Mol Med; 2006 May 01; 17(5):937-44. PubMed ID: 16596284
    [Abstract] [Full Text] [Related]

  • 10. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M, Adachi M, Huang C, Higashiyama M, Kodama K, Taki T.
    Oncogene; 1999 Apr 08; 18(14):2397-404. PubMed ID: 10327061
    [Abstract] [Full Text] [Related]

  • 11. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
    Zhou LY, Liu F, Tong J, Chen QQ, Zhang FW.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 08; 29(3):534-7. PubMed ID: 19304547
    [Abstract] [Full Text] [Related]

  • 12. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
    Liao DW, Wang L, Zhang XG, Liu MQ.
    Ai Zheng; 2006 Oct 08; 25(10):1238-42. PubMed ID: 17059767
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
    Chen TP, Chen CM, Chang HW, Wang JS, Chang WC, Hsu SI, Cho CL.
    Gynecol Oncol; 2007 Mar 08; 104(3):516-23. PubMed ID: 17079005
    [Abstract] [Full Text] [Related]

  • 14. Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer.
    Zhang Z, Chen Z, Song Y, Zhang P, Hu J, Bai C.
    J Pathol; 2010 Jun 08; 221(2):210-20. PubMed ID: 20455256
    [Abstract] [Full Text] [Related]

  • 15. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
    Chung LY, Tang SJ, Sun GH, Chou TY, Yeh TS, Yu SL, Sun KH.
    Clin Cancer Res; 2012 Aug 01; 18(15):4037-47. PubMed ID: 22696230
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y, Wang Y, Xu HT, Yang LH, Wei Q, Liu Y, Zhang Y, Zhao Y, Dai SD, Miao Y, Yu JH, Zhang JY, Li G, Yuan XM, Wang EH.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):518-26. PubMed ID: 19735876
    [Abstract] [Full Text] [Related]

  • 20. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
    Sonobe M, Nakagawa M, Takenaka K, Katakura H, Adachi M, Yanagihara K, Otake Y, Wada H, Tanaka F.
    J Surg Oncol; 2007 Jan 01; 95(1):63-9. PubMed ID: 17192868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.